Options
Matthias Götzfried
Former Member
Title
Dr.
Last Name
Götzfried
First name
Matthias
Phone
+41 71 224 7272
Now showing
1 - 10 of 14
-
PublicationAnalysis of the Implementation of Total Productive Maintenance, Total Quality Management, and Just-In-Time in Pharmaceutical ManufacturingIn the pharmaceutical industry, systems for improving operational effectiveness and efficiency are becoming more and more popular. In this paper, developments in the industry's improvements in operational effectiveness and efficiency have been analyzed. A holistic model is presented which builds the basis for the presented study results. The study includes data gathered from pharmaceutical production sites in surveys in 2004 and 2009. The analysis is divided according to the four sub-systems: Total Productive Maintenance, Total Quality Management, Just-in-Time, and the Management System. For each sub-system, key performance indicators and associated elements (practices and instruments) from 2004 to 2009 are investigated. The data indicates that the industry did make continuous steps towards "Excellence in Operations" between 2004 and 2009. Pharmaceutical companies took control over their former low asset utilization and managed to improve the efficiency of their quality systems; however, they are still far away from having any kind of "continuous flow", smooth production scheduling or make-to-order manufacturing. It can be said that most of the companies are still working on the effectiveness side rather than focusing on the efficiency side.Type: journal articleJournal: Journal of Pharmaceutical InnovationVolume: 5Issue: 4
Scopus© Citations 31 -
PublicationType: journal articleJournal: Innovations in Pharmaceutical TechnologyVolume: 2010Issue: 32
-
PublicationComplexity Index : Assessing the impact of external and internal complexity on production plant performance( 2012-07-01)Managing complexity induced by product variety represents a major challenge for industrial companies. Companies are especially concerned with the assessment of variety-induced complexity at production plants and its impact on operational performance. This paper, following a methodical combination of qualitative and quantitative approaches, presents a complexity index consisting of 20 operational indicators. Taking the index as a basis, the relationship between complexity and operational plant performance is investigated. Finally, two clusters, built on their performance level and ability to transfer high external complexity into low internal complexity, are compared in detail.Type: conference paperVolume: 1. Auflage
-
PublicationOrganising for innovation : Evidence from a study among German manufacturersInnovation Management is becoming a corporate priority to sustain growth rates for technologyintensive manufacturers. However, apart from introducing a formal innovation process, many firms find it difficult to create the proper organisational settings to support their innovation activities. In our study of 86 German manufacturers, we elaborate on selected organisational issues, such as the allocation of innovation responsibility, the design of organisational interfaces etc. to fully understand how these companies organise for innovation today. This paper will present the major findings of the study as well as some concluding remarks on the optimisation of the organisational design of future innovation processes. Fulltext can be downloaded here: http://publica.fraunhofer.de/eprints/urn:nbn:de:0011-n-1156551.pdfType: conference paper
-
PublicationIntroducing Complexity in the Equation: How Pfizer Made Complexity on a Plant Level Transparent(Springer Berlin Heidelberg, 2013)
;Seller, Colin ;Davis, Richard M. ;Basu, PrabirWerani, JürgenManaging complexity induced by product variety represents a major challenge for every industrial company in this world. In the Pharmaceutical Industry the regulatory requirements make the situation even more challenging. Companies are especially concerned with the assessment of variety-induced complexity at production plants and its impact on operational performance. This chapter describes how Pfizer examined the connection between Complexity and Operational Excellence on the plant level and the potential for using the model for identification of operational improvements on the plant, as well as the broader manufacturing network level. The chapter follows a methodical combination of qualitative and quantitative approaches and presents a complexity index consisting of 20 indicators. Taking the index as a basis, the relationship between complexity and operational plant performance is investigated. Finally, two clusters, built on plant performance level and ability to transfer high external complexity into low internal complexity, are compared in detail. In the concluding part, the benefit for Pfizer from taking this perspective and approach on plant performance and on OPEX is described.Type: book section -
Publication
-
Publication
-
-
PublicationMaking Operational Excellence Work : Training and Coaching Supporting Behavioral Change(Editio Cantor, 2010)
;Werani, Jürgen ;Bellando-Randone, Giusal -